304 related articles for article (PubMed ID: 25411276)
1. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.
Whitehead A; Beck EJ; Tosh S; Wolever TM
Am J Clin Nutr; 2014 Dec; 100(6):1413-21. PubMed ID: 25411276
[TBL] [Abstract][Full Text] [Related]
2. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.
Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction
Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
Eur J Clin Nutr; 2016 Nov; 70(11):1239-1245. PubMed ID: 27273067
[TBL] [Abstract][Full Text] [Related]
4. An Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial.
Ms Wolever T; Rahn M; Dioum E; Spruill SE; Ezatagha A; Campbell JE; Jenkins AL; Chu Y
J Nutr; 2021 Sep; 151(9):2655-2666. PubMed ID: 34236436
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects.
Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211
[TBL] [Abstract][Full Text] [Related]
6. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yu J; Xia J; Yang C; Pan D; Xu D; Sun G; Xia H
Nutrients; 2022 May; 14(10):. PubMed ID: 35631184
[TBL] [Abstract][Full Text] [Related]
7. Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults.
Ibrügger S; Kristensen M; Poulsen MW; Mikkelsen MS; Ejsing J; Jespersen BM; Dragsted LO; Engelsen SB; Bügel S
J Nutr; 2013 Oct; 143(10):1579-85. PubMed ID: 23946347
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial.
Wolever TM; Tosh SM; Gibbs AL; Brand-Miller J; Duncan AM; Hart V; Lamarche B; Thomson BA; Duss R; Wood PJ
Am J Clin Nutr; 2010 Oct; 92(4):723-32. PubMed ID: 20660224
[TBL] [Abstract][Full Text] [Related]
9. Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians.
Wolever TM; Gibbs AL; Brand-Miller J; Duncan AM; Hart V; Lamarche B; Tosh SM; Duss R
Nutr J; 2011 Nov; 10():130. PubMed ID: 22118569
[TBL] [Abstract][Full Text] [Related]
10. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial.
Queenan KM; Stewart ML; Smith KN; Thomas W; Fulcher RG; Slavin JL
Nutr J; 2007 Mar; 6():6. PubMed ID: 17386092
[TBL] [Abstract][Full Text] [Related]
11. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults.
Maki KC; Shinnick F; Seeley MA; Veith PE; Quinn LC; Hallissey PJ; Temer A; Davidson MH
J Nutr; 2003 Mar; 133(3):808-13. PubMed ID: 12612157
[TBL] [Abstract][Full Text] [Related]
12. Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults.
Charlton KE; Tapsell LC; Batterham MJ; O'Shea J; Thorne R; Beck E; Tosh SM
Br J Nutr; 2012 Apr; 107(7):1037-47. PubMed ID: 21810288
[TBL] [Abstract][Full Text] [Related]
13. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies.
Hollænder PL; Ross AB; Kristensen M
Am J Clin Nutr; 2015 Sep; 102(3):556-72. PubMed ID: 26269373
[TBL] [Abstract][Full Text] [Related]
14. High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults.
Wang Y; Harding SV; Eck P; Thandapilly SJ; Gamel TH; Abdel-Aal el-SM; Crow GH; Tosh SM; Jones PJ; Ames NP
J Nutr; 2016 Apr; 146(4):720-7. PubMed ID: 26936139
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels.
Tiwari U; Cummins E
Nutrition; 2011 Oct; 27(10):1008-16. PubMed ID: 21470820
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering properties of oat β-glucan and the promotion of cardiovascular health: did Health Canada make the right call?
Nwachukwu ID; Devassy JG; Aluko RE; Jones PJ
Appl Physiol Nutr Metab; 2015 Jun; 40(6):535-42. PubMed ID: 25933163
[TBL] [Abstract][Full Text] [Related]
17. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
Biörklund M; Holm J; Onning G
Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
[TBL] [Abstract][Full Text] [Related]
18. Effect of Oat (Avena sativa L.) Consumption on Lipid Profile With Focus on Triglycerides and High-density Lipoprotein Cholesterol (HDL-C): An Updated Systematic Review.
Amerizadeh A; Ghaheh HS; Vaseghi G; Farajzadegan Z; Asgary S
Curr Probl Cardiol; 2023 Jul; 48(7):101153. PubMed ID: 35192870
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. High molecular weight oat β-glucan enhances lipid-lowering effects of phytosterols. A randomised controlled trial.
Ferguson JJ; Stojanovski E; MacDonald-Wicks L; Garg ML
Clin Nutr; 2020 Jan; 39(1):80-89. PubMed ID: 30792143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
